Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02538434
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
MNY | 5,8-DI-AMINO-1,4-DIHYDROXY-ANTHRAQUINONE | A | 1M2R | 0.76 | |
P9C | 3-({3-[(1S,4S,4aS,6S,7S,9S,9aR)- 1,6-dimethyl-2-oxo-4-phenyldecahydro- 6,9-epoxy-4a,7-methanobenzo[7]annulen- 1-yl]propanoyl}amino)-2,4-dihydroxybenzoic acid | A | 3G11 | 0.71 | |
968 | 2-[(7-HYDROXY-NAPHTHALEN-1-YL)- OXALYL-AMINO]-BENZOIC ACID | A | 1ONZ | 0.75 | |
ANY | 2-METHYL-BUTYRIC ACID 3-(3-FORMYLAMINO- 2-HYDROXY-BENZOYLAMINO)-8-HEPTYL- 2,6-DIMETHYL-4,9-DIOXO-[1,5]DIOXONAN- 7-YL ESTER | A,C,D,E,N,P, Q,R | 3H1I | 0.71 | |
ANY | 2-METHYL-BUTYRIC ACID 3-(3-FORMYLAMINO- 2-HYDROXY-BENZOYLAMINO)-8-HEPTYL- 2,6-DIMETHYL-4,9-DIOXO-[1,5]DIOXONAN- 7-YL ESTER | A,B,C,D,E,F, G,O,P,Q,R,S,T | 1PPJ | 0.71 | |
AMY | ANTIMYCIN | C,D,E | 3BCC | 0.71 | |
P9A | 3-({3-[(1S,4aS,6S,7S,9S,9aR)-1,6- dimethyl-2-oxodecahydro-6,9-epoxy- 4a,7-methanobenzo[7]annulen-1-yl]propanoyl}amino)- 2,4-dihydroxybenzoic acid | A | 3G0Y | 0.72 | |
TNC | 4-DIMETHYLAMINO-1,10,11,12-TETRAHYDROXY- 3-OXO-3,4,4A,5-TETRAHYDRO-NAPHTHACENE- 2-CARBOXYLIC ACID AMIDE | A,B | 1N5Q | 0.72 | |
TDC | 5A,6-ANHYDROTETRACYCLINE | A | 2VKV | 0.84 | |
TDC | 5A,6-ANHYDROTETRACYCLINE | A | 2VPR | 0.84 | |
CTC | 7-CHLOROTETRACYCLINE | A | 1BJ0 | 0.76 | |
CTC | 7-CHLOROTETRACYCLINE | A,B | 1BJY | 0.76 | |
CTC | 7-CHLOROTETRACYCLINE | A | 2FJ1 | 0.76 | |
CTC | 7-CHLOROTETRACYCLINE | A | 1DU7 | 0.76 | |
CTC | 7-CHLOROTETRACYCLINE | A,B | 3EGZ | 0.76 | |
CTC | 7-CHLOROTETRACYCLINE | A | 2TCT | 0.76 | |
MIX | 1,4-DIHYDROXY-5,8-BIS({2-[(2-HYDROXYETHYL)AMINO]ETHYL}AMINO)- 9,10-ANTHRACENEDIONE | A,B,C,D | 2FUM | 0.79 | |
ANJ | (2R,3S,6S,7R,8R)-3-{[3-(FORMYLAMINO)- 2-HYDROXYBENZOYL]AMINO}-8-HEXYL- 2,6-DIMETHYL-4,9-DIOXO-1,5-DIOXONAN- 7-YL (2S)-2-METHYLBUTANOATE | A,B,C,D,E,F, G,H,I,J,K,L | 2QJP | 0.71 | |
ANJ | (2R,3S,6S,7R,8R)-3-{[3-(FORMYLAMINO)- 2-HYDROXYBENZOYL]AMINO}-8-HEXYL- 2,6-DIMETHYL-4,9-DIOXO-1,5-DIOXONAN- 7-YL (2S)-2-METHYLBUTANOATE | A,B,C,D,E,F, G,H,I,J,K,L, M,N,O,P,Q,R | 2QJK | 0.71 | |
ATC | 9-(N,N-DIMETHYLGLYCYLAMIDO)-6-DEOXY- 6-DEMETHYL-TETRACYCLINE | A | 1ORK | 0.85 | |
989 | 2-{[4-(2-ACETYLAMINO-2-PENTYLCARBAMOYL- ETHYL)-NAPHTHALEN-1-YL]-OXALYL- AMINO}-BENZOIC ACID | A | 1NL9 | 0.71 | |
HNA | 1,8-DI-HYDROXY-4-NITRO-ANTHRAQUINONE | A | 1M2P | 0.72 | |
MIY | (4S,4AS,5AR,12AS)-4,7-BIS(DIMETHYLAMINO)- 3,10,12,12A-TETRAHYDROXY-1,11-DIOXO- 1,4,4A,5,5A,6,11,12A-OCTAHYDROTETRACENE- 2-CARBOXAMIDE | A | 2DRD | 0.94 | |
TAC | TETRACYCLINE | A,B,C,D,E,F, G,H,I,J,K,L | 2HDN | 0.81 | |
TAC | TETRACYCLINE | A | 2VKE | 0.81 | |
TAC | TETRACYCLINE | A | 2TRT | 0.81 | |
TAC | TETRACYCLINE | B | 2UXO | 0.81 | |
TAC | TETRACYCLINE | A,B,D,E,G,H, J,K,L,N,P,Q, R,T | 1I97 | 0.81 | |
TAC | TETRACYCLINE | A,D,H,N | 1HNW | 0.81 | |
TAC | TETRACYCLINE | A,B | 2HCJ | 0.81 | |
DXT | (4S,4AR,5S,5AR,6R,12AS)-4-(DIMETHYLAMINO)- 3,5,10,12,12A-PENTAHYDROXY-6-METHYL- 1,11-DIOXO-1,4,4A,5,5A,6,11,12A- OCTAHYDROTETRACENE-2-CARBOXAMIDE | A | 2O7O | 0.8 | |
NAB | A,B | 1SRJ | 0.71 | ||
C00 | 2-(4-hydroxybiphenyl-3-yl)-4-methyl- 1H-isoindole-1,3(2H)-dione | A | 3BYX | 0.7 | |
C00 | 2-(4-hydroxybiphenyl-3-yl)-4-methyl- 1H-isoindole-1,3(2H)-dione | A | 3BZ0 | 0.7 | |
421 | 6-CARBAMIMIDOYL-4-(3-HYDROXY-2- METHYL-BENZOYLAMINO)-NAPHTHALENE- 2-CARBOXYLIC ACID METHYL ESTER | A | 1ZSK | 0.71 | |
95A | TMC-95A | D,F,G,H,I,L, N,O,P | 1JD2 | 0.72 | |
PMN | PLATENSIMYCIN | A | 2GFX | 0.72 | |
709 | N-(7-CARBAMIMIDOYL-NAPHTHALEN-1- YL)-3-HYDROXY-2-METHYL-BENZAMIDE | A | 1ZSJ | 0.73 |